EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer

Junhuan Xia iD, Jingwen Tian, Yuting Cao iD, Suhan Zhang, Weiye Qian, Yanan Qi, Hao Huang iD

NAR Cancer · 2026

DOI: 10.1093/narcan/zcag026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, 2026. Verfasst von Junhuan Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, No. 2 SEU Road, Nanj…. Hauptthemen laut MEDLINE: Breast Neoplasms, Machine Learning, Enhancer RNAs, Biomarkers, Tumor. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Undergraduate Training Programs for Innovation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current breast cancer biomarkers rely predominantly on protein-coding transcriptomes, leaving the regulatory information encoded by enhancer RNAs (eRNAs) largely unexploited. Here, we profiled eRNA expression across 1073 The Cancer Genome Atlas Breast Cancer (TCGA-BRCA) samples integrated with The Cancer eRNA Atlas annotations, using GTEx healthy breast tissue (n = 179) as a curated normal reference. For prognostic stratification, least absolute shrinkage and selection operator (LASSO)-Cox regression identified a 10-eRNA signature that stratified patients into high- and low-risk groups in both training (P <.0001) and independent testing cohorts (P = 0.0022), with a 3-year time-dependent area under the curve (AUC) of 0.743. Multivariate Cox analysis confirmed the signature as an independent predictor [hazard ratio = 3.176, 95% confidence interval (CI): 2.075–4.864, P <.001]. Multi-omics network integration linked these prognostic eRNAs to regulatory hubs centered on the ESR1/FOXA1/GATA3/AR axis. For early-stage detection, we developed a 19-eRNA panel via bootstrap LASSO feature selection and benchmarked ten classifiers; a Multilayer Perceptron achieved the best generalization (AUC = 0.959, 95% CI: 0.925–0.986) on an independent cohort (GSE225846). Both modules were deployed in eRNACare, a publicly accessible web application for individualized survival and tumor probability scoring. These findings establish eRNAs as a complementary noncoding layer to conventional messenger RNA classifiers, with clinical potential for breast cancer risk stratification, therapeutic guidance, and early detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMachine LearningEnhancer RNAsBiomarkers, TumorHumansFemalePrognosisMultiomicsGene Expression ProfilingEarly Detection of CancerGene Expression Regulation, NeoplasticTranscriptome

Substanzen

Enhancer RNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, No. 2 SEU Road, Nanjing 211189, Jiangsu, China.

ORCID-Profile: Junhuan Xia, Yuting Cao, Hao Huang

Förderung

  • Undergraduate Training Programs for Innovation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Xia, J., Tian, J., Cao, Y., Zhang, S., Qian, W., Qi, Y., & Huang, H. (2026). Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer. NAR Cancer. https://doi.org/10.1093/narcan/zcag026

Vancouver

Xia J, Tian J, Cao Y, Zhang S, Qian W, Qi Y, et al. Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer. NAR Cancer. 2026. doi:10.1093/narcan/zcag026

BibTeX
@article{Xia2026,
  author = {Xia, Junhuan and Tian, Jingwen and Cao, Yuting and Zhang, Suhan and Qian, Weiye and Qi, Yanan and Huang, Hao},
  title = {Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer},
  journal = {NAR Cancer},
  year = {2026},
  doi = {10.1093/narcan/zcag026}
}
Kostenlos starten →